TSOI Products
8 Biologics, 8 Nutraceuticals, 1 Pharmaceutical = 17
8 Biologics
innaMune
Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator
MemoryMune
Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
StemVacs
StemVacs | Immunotherapy Platform
BRS-001
Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" ...
sRNA augmented stem cells
Therapeutic Solutions International Expands Chronic Traumatic Encephalopathy Intellectual Property Portfolio
JadiCell MSCs
https://ih.advfn.com/stock-market/U...peutic-solutions-international-signs-agreemen
Autologous Neurogenic Stem Cell Banking
http://ih.advfn.com/stock-market/US...peutic-solutions-international-continues-to-e
"Educated" Monocytes / Projenitors
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-e
8 Nutraceuticals
Projuvenol
http://projuvenol.com/
NanoStilbene
http://nanostilbene.com/
DermalStilbene
http://ih.advfn.com/stock-market/US...apeutic-solutions-international-releases-derm
IsoStilbene
https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos
NeuroStilbene
https://ih.advfn.com/stock-market/U...erapeutic-solutions-international-inc-release
Alpha Lipoic Acid
https://ih.advfn.com/stock-market/U...peutic-solutions-international-develops-micro
Cancer Metabolic DeTox
http://www.marketwired.com/press-re...rough-nutraceutical-otc-pink-tsoi-2215015.htm
NanoStilbene w/ PKE
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r
1 Pharmaceutical
LymphoBoost
http://www.marketwired.com/press-re...munity-mifepristone-otc-pink-tsoi-2217703.htm
4 nutraceutical products for sale online
Projuvenol, NanoStilbene, DermalStilbene (x2)
http://www.youcanordernow.com/
4 Biologics, 3 Nutraceuticals, 1 Pharmaceutical licensed to Pan Am Cancer Treatment Center in Mexico
StemVacs, innaMune, MemoryMune, BRS-001, Cancer Metabolic DeTox, NanoStilbene, IsoStilbene, LymphoBoost
http://ih.advfn.com/p.php?pid=nmona&article=77606645
http://ih.advfn.com/p.php?pid=nmona&article=77309980
http://ih.advfn.com/p.php?pid=nmona&article=77635806
https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos
Pan Am Cancer Treatment Center Introductory Tour Video
https://www.youtube.com/watch?v=rWgJLRCICa8&feature=youtu.be
TSOI Patents
http://therapeuticsolutionsint.com/?page_id=68
TSOI Patent Search
https://patents.google.com/?assignee=Therapeutic+Solutions+International+Inc
TSOI Scientific Advisory Board Members
https://therapeuticsolutionsint.com/?page_id=64
NEWS 2/19/19
Therapeutic Solutions International Continues to Refine NanoStilbene™ Formulation
NanoStilbene Shown to Reduce Tumor Necrosis Factor-a (TNF-a ) in Cancer Patients
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r
OCEANSIDE, CA -- February 19, 2019 -- InvestorsHub NewsWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today further refinement of their patented formulation of nanoparticle pterostilbene known as NanoStilbene™.
NanoStilbene™ is a nanoemulsion of nanoparticle pterostilbene in the 75-90nm (nanometer) range at a concentration of 200mg per milliliter. We have successfully produced the same stable nanoemulsion using peach kernel extract to fortify the NanoStilbene against tumor necrosis factor-a (TNF-a ).
"We recently announced the conclusion of a clinical trial involving 12 advanced, solid tumor, cancer patients who received the equivalence of 300mg's of nanoparticle pterostilbene daily for three weeks which showed on average a 26% decrease in TNF-a 1," said Tim G Dixon CEO & President of Therapeutic Solutions International, Inc. "By adding peach kernel extract to our nanoemulsion formulation we intend to fortify NanoStilbene to be even more effective against high levels of inflammatory cytokines."
"In a recent paper, peach kernel extract has been shown to reduce tissue factor (TF) elevations in atherosclerosis, which is a pathological process in arteries due to plaque formation, by first reducing tumor necrosis factor-a (TNF-a)2," said Dr. Thomas Ichim, Director of Therapeutic Solutions International. "Tumor necrosis factor (TNF) is a type of messenger protein known as a cytokine that is produced by white blood cells. It promotes inflammation, produces other cells used in the inflammatory response, and can help cells heal" added Dr. Ichim.
"By adding the peach kernel extract to the nanoemulsion formulation, our purpose is to open the way for new therapeutic approaches that might eventually decrease the prevalence of tumor necrosis factor-a (TNF-a) in not only cancer patients where TNF-a has been shown to play a key role in these inflammatory processes but also in acute and chronic inflammatory conditions such as trauma, sepsis, infection, rheumatoid arthritis, atherosclerosis, and cardiovascular disease" said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International.
TNF-a is a member of a growing family of peptide mediators comprising at least 19 cytokines, including lymphotoxin-, Fas ligand, and CD40 ligand. TNF-a has important proinflammatory properties, which play crucial roles in the innate and adaptive immunity, cell proliferation, and apoptotic processes. The cytokine is produced by different kind of cells, including macrophages, monocytes, T-cells, smooth muscle cells, adipocytes, and fibroblasts.
TSOI NEWS HISTORY 5/1/18 - 1/22/19
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146277441
SHARE STRUCTURE
https://www.otcmarkets.com/stock/TSOI/security
AS - 2.5 B common , 5 M preferred -
https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=LvtIoYTPV6wB1RIovm008A%3d%3d&nt7=0
IO - 1,084,613,182
Restricted - 909,729,214
Unrestricted - 174,883,968
Held at DTC - 152,240,968
Float - 105,109,529
SEC Filings
https://www.sec.gov/cgi-bin/browse-...nternational&match=contains&action=getcompany
Transfer Agent
New Horizon Transfer Inc.
215-515 West Pender Street
Vancouver, BC V6B 6H5
CAN(604) 876-5526
www.newhorizontransfer.com
TSOI Management / Board of Directors
https://therapeuticsolutionsint.com/?page_id=62
Contact
Investor Relations
ir@tsoimail.com
Corporate Website
Therapeutic Solutions International, Inc. |
Additional info
http://projuvenol.com/
https://nanostilbene.com/
https://stemvacs.com/
E Commerce Site
www.youcanordernow.com/
TSOI Facebook
https://www.facebook.com/tsoihome/
TSOI Twitter
https://twitter.com/tsoisupplement
https://twitter.com/search?f=tweets&vertical=default&q=$TSOI&src=typd
Disclaimer : All of the information presented in the IBOX , Stickies , or posts on this board , is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .